Back to Journals » Cancer Management and Research » Volume 11

Postoperative morbidity and mortality after neoadjuvant chemotherapy versus upfront surgery for locally advanced gastric cancer: a propensity score matching analysis

Authors Wu L, Ge L, Qin Y, Huang M, Chen J, Yang Y, Zhong J

Received 1 February 2019

Accepted for publication 31 May 2019

Published 3 July 2019 Volume 2019:11 Pages 6011—6018

DOI https://doi.org/10.2147/CMAR.S203880

Checked for plagiarism Yes

Review by Single-blind

Peer reviewers approved by Dr Colin Mak

Peer reviewer comments 2

Editor who approved publication: Dr Eileen O'Reilly


Liucheng Wu,1 Lianying Ge,2 Yuzhou Qin,1 Mingwei Huang,1 Jiansi Chen,1 Yang Yang,1 Jianhong Zhong3

1Department of Gastrointestinal Surgery, Affiliated Tumor Hospital of Guangxi Medical University, Nanning, Guangxi Autonomous Region 530021, People’s Republic of China; 2Department of Endoscopy, Affiliated Tumor Hospital of Guangxi Medical University, Nanning, Guangxi Autonomous Region 530021, People’s Republic of China; 3Department of Hepatobilliary Surgery, Affiliated Tumor Hospital of Guangxi Medical University, Nanning, Guangxi Autonomous Region 530021, People’s Republic of China

Background: Cohort studies have shown that neoadjuvant chemotherapy (NAC) is not associated with increased risk of postoperative complications and mortality as compared to upfront surgery (SURG).
Objective: The aim of this study was to compare postoperative morbidity and mortality after NAC with SURG.
Patients and methods: Patients who underwent gastrectomy with D2 lymphadenectomy for advanced gastric cancer (GC) between 2010 and 2017 were selected. The impact of neoadjuvant chemotherapy on surgical safety was investigated by using propensity score matching.
Results: Three hundred and seventy-seven patients were included. After propensity score matching, 86 patients in each group were matched. The percentage of patients with one or more complications was 10.5% in NAC group and 15.1% in SURG group (P=0.361), there was no mortality developed in either group. The total blood loss was significantly more in the NAC group than that in the SURG group (320.79 vs 243.37 ml, P<0.04). In univariate and multivariate of the matched cohort, sex, age (<70), BMI (<24), ASA grade, surgical procedure (open vs laparoscopy), gastrectomy extent, cTNM and Charlson index comorbidity were not associated with postoperative complications (all P>0.05).
Conclusion: This study showed that postoperative morbidity and mortality were similar for NAC group and SURG group.

Keywords: gastric cancer, surgery, postoperative morbidity, propensity score, neoadjuvant chemotherapy

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]